Advertisement

Science

Advertisement

Recent Headlines

U.S. health advisors have endorsed a one-dose COVID-19 vaccine from Johnson & Johnson that’s expected to provide an easier-to-use option to fight the pandemic.

Scientists have identified a mutated version of the coronavirus spreading in New York, one of several variants being monitored in the U.S.

Pfizer says it has begun studying the effects of a third dose of its COVID-19 vaccine, part of a strategy to combat new versions of the coronavirus.

Many in the marginalized Latino LGBTQ community, a number of whom are frontline workers, have been deeply affected by the pandemic and are unable to find help.

February is usually the peak of flu season but not this year, in part because of measures, such as mask-wearing, to fight the coronavirus.

After 90 days, the immunity developed in response to a coronavirus infection is about as protective as a COVID-19 vaccine, according to a new study.

COVID-19 vaccine makers tell Congress to expect a big jump in the delivery of doses over the coming month.

Sales of pet supplements soared by 21% last year as people tried to protect their furry friends from COVID-19. Experts say there’s no need.

COVID-19 vaccines adapted for new coronavirus variants can receive authorization from the Food and Drug Administration without repeating full clinical trials.

Scotland’s COVID-19 vaccination program has led to a sharp drop in hospitalizations, offering some real-world evidence of the shots’ impact.

In L.A., so many people now have immunity to the coronavirus from past infections and vaccination that transmission is slowing and inching toward herd immunity.

U.S. life expectancy fell in the first half of 2020 amid the pandemic: almost three years for Black people, two for Latinos and one for white people.

Reversals of fortune, political quarrels and vexing public-health paradoxes are complicating efforts to contain a deadly third wave of contagion across Europe.

Covid-19 Vaccines

The concerns over patient privacy offer a glimpse into questions being raised about the scope of Blue Shield’s role as an independent overseer of California’s network of COVID-19 vaccine providers.

More headlines

Advertisement
Advertisement
Advertisement